Viewing nowPioglitazone 15 mg Tablets (Pioglitazone Hydrochloride)
Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Medica Korea Co., Ltd.

MFDS item code 202003843 · Approved 2020.05.26 · Insurance code 646005150
Improvement of type 2 diabetes (blood sugar control)
This medication is used in conjunction with dietary and exercise therapy to assist blood sugar control in patients with type 2 diabetes. It can also be administered as a monotherapy, but if the blood sugar improvement is insufficient, it may be combined with sulfonylureas, metformin, or insulin. Additionally, patients should also implement nutritional counseling, weight loss, and regular exercise; these efforts are essential for maintaining the efficacy of the medication. This medicine is used to improve blood sugar control.
This medication is taken orally once daily, regardless of meals. As monotherapy, it starts at 15 mg once daily, and if the effect is insufficient, the dosage can be increased to 30 mg once daily. In combination therapy, it is also given at 15 mg once daily, with the maximum recommended dose not exceeding 30 mg once daily.
There is no experience in children under 18 years of age, so administration is not recommended.
This medication is used in the treatment of type 2 diabetes and demonstrates a lowering effect on blood sugar in conjunction with insulin. This medication may impose a burden on heart function in some patients, so it should not be taken by patients with heart failure or a history of heart failure. Fluid retention may occur during treatment, leading to edema or worsening of heart failure, so symptoms such as weight changes, difficulty breathing, or leg swelling should be carefully monitored. Patients with active bladder cancer or a history of bladder cancer should also avoid this medication, and they must immediately inform a physician if they experience visible hematuria or urinary disturbances. Patients with impaired liver function or severe kidney impairment, as well as women who are pregnant or may become pregnant, must consult a physician before using this medication. When combined with other blood sugar-lowering agents, the risk of hypoglycemia may increase, necessitating dosage adjustments for the co-administered medications. During treatment, regular blood sugar tests and liver function tests are required, and if symptoms of edema or heart failure appear, medical advice should be sought immediately. Additionally, this medication may induce ovulation in premenopausal women, so it is recommended to use adequate contraceptive methods during treatment. Patients should report any sudden weight gain, swelling, or shortness of breath to their doctor immediately, and it is advisable to have regular eye examinations to monitor eye health. Elderly patients or those with impaired kidney and liver function should use this medication with increased caution, and it is crucial to inform healthcare professionals promptly in case of any adverse reactions. While taking this medication, it is essential to consistently adhere to the prescribed dosage of once daily, and if a dose is missed, care should be taken not to double the dose the following day. In the event of overdose, appropriate treatment should be administered based on symptoms, and the medication should be stored out of reach of children.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a container that is protected from light and air, and it should be kept away from humid places. The storage temperature should be between 15 and 30 degrees, with 25 degrees considered optimal for room temperature storage.
White round tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Medica Korea Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Hanol Bio Pharma Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kyungdong Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.